T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Pediatrix Medical
MD
$2.15B
| $120M | 0.02% |
4,740,487
-2,149,278
| -31% | -$57.7M |
|
602
FTI Consulting
FCN
$4.22B
| $119M | 0.02% |
1,419,201
-12,934
| -0.9% | -$1.06M |
|
603
Fair Isaac
FICO
$22.6B
| $119M | 0.02% |
378,073
-97,580
| -21% | -$28.3M |
|
604
Valero Energy
VLO
$95.1B
| $118M | 0.02% |
1,382,672
-268,650
| -16% | -$22.2M |
|
|
ALEX
605
DELISTED
Alexander & Baldwin
ALEX
| $117M | 0.02% |
5,069,244
-858,855
| -14% | -$20.4M |
|
|
ZNGA
606
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $117M | 0.02% |
19,051,410
-706,294
| -4% | -$4.16M |
|
|
STFC
607
DELISTED
State Auto Financial Corp
STFC
| $116M | 0.02% |
3,319,444
+76,718
| +2% | +$2.61M |
|
608
Upwork
UPWK
$1.05B
| $116M | 0.02% |
7,221,947
-4,155,514
| -37% | -$71.6M |
|
609
Seacoast Banking Corp of Florida
SBCF
$3.44B
| $114M | 0.02% |
4,494,716
-148,491
| -3% | -$3.86M |
|
610
PRA Group
PRAA
$737M
| $114M | 0.02% |
4,060,994
+82,619
| +2% | +$2.34M |
|
|
SWAV
611
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $114M | 0.02% |
2,057,775
+162,999
| +9% | +$7.92M |
|
612
Matador Resources
MTDR
$6.5B
| $114M | 0.02% |
5,725,552
-315,600
| -5% | -$5.99M |
|
|
MINI
613
DELISTED
Mobile Mini Inc
MINI
| $113M | 0.02% |
3,722,873
-2,936,414
| -44% | -$97.5M |
|
614
APA Corp
APA
$14B
| $112M | 0.02% |
3,881,901
-376,472
| -9% | -$11.7M |
|
615
Encore Capital Group
ECPG
$2.07B
| $112M | 0.02% |
3,308,104
+191,768
| +6% | +$6.22M |
|
|
KYNB
616
Kyntra Bio
KYNB
$28.7M
| $112M | 0.02% |
99,160
-2,732
| -3% | -$2.99M |
|
617
Fox Class A
FOXA
$26.5B
| $112M | 0.02% |
3,043,664
+1,399,819
| +85% | +$51.4M |
|
618
Voya Financial
VOYA
$9.01B
| $111M | 0.02% |
2,012,962
-792,913
| -28% | -$42.5M |
|
619
Phillips 66
PSX
$90B
| $111M | 0.02% |
1,185,273
-282
| -0% | -$25.3K |
|
620
Take-Two Interactive
TTWO
$45.4B
| $111M | 0.02% |
974,989
-1,208,853
| -55% | -$124M |
|
621
ICICI Bank
IBN
$107B
| $110M | 0.02% |
8,746,777
+8,272,545
| +1,744% | +$95.9M |
|
622
Texas Capital Bancshares
TCBI
$4.38B
| $110M | 0.02% |
1,787,721
-908,314
| -34% | -$55.2M |
|
|
AIMT
623
DELISTED
Aimmune Therapeutics
AIMT
| $109M | 0.02% |
5,246,604
+535,072
| +11% | +$11M |
|
624
Safety Insurance
SAFT
$1.52B
| $109M | 0.02% |
1,142,407
-3,036
| -0.3% | -$282K |
|
|
HTO
625
H2O America
HTO
$2.62B
| $108M | 0.02% |
1,779,259
-47,205
| -3% | -$2.91M |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.